Vulnerability · Published Jan 21, 2022 · Assigned by icscert

CVE-2021-33848Fresenius Kabi Agilia Connect Infusion System cross site scripting

Medium 5.4

In plain English

A medium-severity cross-site scripting in Vigilant Software Suite (Mastermed Dashboard) from Fresenius Kabi. There are no confirmed reports of exploitation so far. The chance it is exploited in the next 30 days is estimated at 0.6% (higher than 49% of all known vulnerabilities).

Severity (CVSS 3.1)5.4Medium

Exploit odds (30 days)0.6%top 50.6% of all CVEs

Exploited in the wildNo reportsCISA SSVC: none

Attack toolingNoneno public tooling known

Official description

Fresenius Kabi Vigilant Software Suite (Mastermed Dashboard) version 2.0.1.3 is vulnerable to reflected cross-site scripting attacks. An attacker could inject JavaScript in a GET parameter of HTTP requests and perform unauthorized actions such as stealing internal information and performing actions in context of an authenticated user.

Affected products (as reported)

Vendor	Product	Versions
Fresenius Kabi	Vigilant Software Suite (Mastermed Dashboard)	unspecified – before 2.0.1.3

Weakness: CWE-79 · Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:N

References

https://www.cisa.gov/uscert/ics/advisories/icsma-21-355-01 x_refsource_MISC